Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectIdiopathic Pulmonary Fibrosis Disease Treatment: Global Markets
This report provides an overview of the idiopathic pulmonary fibrosis (IPF). It outlines perspective on the drugs and therapies used for the management of IPF, including forecast trends and sales through 2024. Important manufacturers, technologies and factors influencing demand are discussed.
Global Markets for Treatment and Diagnosis of Sexually Transmitte...
The global market for sexually transmitted disease diagnostics should grow from $7.6 billion in 2020 to $10.6 billion by 2025 at compound annual growth rate (CAGR) of 7.0% for the period of 2020-2025.
Phenylketonuria Treatment Market: A BCC Research Perspective
The goals of this study were to understand the current market scenario for the treatment options of phenylketonuria (PKU) which includes food for medical purposes (FSMPs), and to assess the market’s growth potential through the end of 2025. This study explores market dynamics such as drivers, restraints, opportunities, and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current treatment market for phenylketonuria and the future directions of the market.
Acne Drugs: Global Markets
The global acne drugs market should reach $7.9 billion by 2025 from $5.9 billion in 2020 at a compound annual growth rate (CAGR) of 5.7% for the forecast years, 2020 to 2025.
Outsourcing Market for Drug and Medical Device Development: Servi...
The global outsourcing services market for drug and medical device development is expected to grow from 130.5 billion pounds in 2020 to 205.6 billion pounds by 2025 with a compound annual growth rate (CAGR) of 9.5% for the period of 2020-2025.
Cannabidiol (CBD) Oil: Global Markets
The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at compound annual growth rate (CAGR) of 40.4% for the period of 2020-2025.
Global Market Opportunities and Competitive Landscape for CDMO
CDMO is an evolving industry with abundant growth opportunities for service providers. CDMO industry is trending towards consolidation; thus, CDMO companies are evolving as integrated pharmaceutical service providers or one-stop solution providers. This report provides details on the CDMO industry including the future trends and latest developments.
Pharmaceuticals for Women's Health: Global Markets
The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.
Pharmaceutical Pricing and Reimbursement: Global Markets
The global pharmaceuticals market was valued at $1,058 billion in 2019 and should reach $1,520 billion by 2024 with a compound annual growth rate (CAGR) of 7.5% from 2019 to 2024.
Global Market for Pain Management Patches
The global market for pain management patches should grow from $4.2 billion in 2018 to $5.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.5% for the period of 2018-2023.
Rare Disease Diagnostics: Technologies and Global Markets
The global rare disease diagnostics market should reach $26.7 billion by 2024 from $17 billion in 2019 at a compound annual growth rate (CAGR) of 9.5% for the forecast period of 2019 to 2024.
Pandemic Outbreaks in the Past Decade: A BCC Research Overview
This report focuses on epidemiology, research and development, current treatment and diagnostics and global response to selected pandemics of the past decade (2009-2020). The report discusses lessons learned from previous outbreaks in terms of policies and measures of prevention and control.
Health Technology Assessment in Pharma: A Review of Major Decisio...
The goal of this study is to provide information on the global health technology approval process in North America, Europe and the Asia-Pacific region. The study emphasizes the role of HTA and its function and technology process in the pharmaceutical industry. The report also elaborates on recent HTA approvals and their significance on pricing and reimbursement.
Nanotechnology in Cancer Treatment
According to the National Science Foundation (NSF) the term nano refers to particles, structures, or devices having at least one dimension below 100 nm. Development, manufacturing and sale of these products have spawned a multibillion industry, commonly referred to as the nanotechnology sector. This report gives a market outlook of nanotechnology in cancer treatment and provides information on its most relevant applications. The major trends, issues and recent achievements in nanotechnology-based cancer treatment are also discussed.
Hyperkalemia Market: A BCC Research Perspective
The hyperkalemia market is currently a flourishing market, with a strong drug pipeline and upcoming technologies for the diagnosis of conditions. This report on Hyperkalemia Market highlights market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. BCC Research focuses on the comprehensive analysis of the current market for hyperkalemia and the future direction of the market.
Medical Affairs: The Roadmap to 2025
This report on Medical Affairs highlights overall growth due to rapidly changing pharmaceutical and medical device markets by forming new paradigms and employing marketing strategies that increase market share. The research will provide information on leading market competitors, their market share, partnerships, collaborations, mergers and acquisitions between pharmaceutical companies. BCC Research focuses on the importance of medical affairs in communicating and collecting the medical evidence with the organization and external stakeholders.
Bioinks: The Living Foundation of Functional Bioprinting
The goal of this short study is to help companies operating within the life science sector gain valuable insights on bioinks by providing an overview of types, compositions, and applications of bioinks. This report outlines the trends that are expected to contribute to market growth for these materials.
Non-injectable Insulin
This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: ...
In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.
ROI in Pharmaceutical R&D: How to Halt the Decline
This report is designed to investigate recent years of performance of pharmaceutical and biopharmaceutical companies with respect to return on investment (ROI) in research and development (R&D), and to discuss ways that companies are trying to improve ROI through 2024. Investigation will include Country/Regional market trends with top areas of return, 2014-2024. This report also looks at which companies are already using artificial intelligence (AI) and machine learning (ML) to successfully compete globally.
Pediatric Medicines: Global Markets
The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.
Cannabis Market: Products, Technologies and Applications
The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.
Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportuniti...
This report on Over-the-Counter (OTC) drugs and dietary supplement products market highlights primary healthcare and its various parameters such as the drafting of rules and regulations for OTC drugs and dietary supplements, the number of drugs classified, self-care awareness among consumers and the size of distribution networks, OTC drugs and dietary supplements manufacturers. BCC Research analyzed key categories and regions to determine the present and future OTC drugs and dietary supplement products market status and forecasted market growth.
Significant Drug Launches in 2019: A BCC Research Analysis and In...
This report provides information on significant drug launches in 2019. The study provides an overview of each drug, scientific summaries, pharmacodynamics, pharmacokinetics and clinical trial information, disease backgrounds, analysis of the market, competitors and company profiles of manufacturers. The objective of this study is to present a comprehensive analysis of the current market and its future direction.
Communicable Disease Market: A BCC Research Overview
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.
Choose your License
Softgel Capsules: Global Markets
This report provides a detailed overview of the softgel capsules market.
Global Market Opportunities and Competitive Landscape for CDMO
This report provides an overview of the pharmaceutical & biotechnology industry, and the role contract development and manufacturing organizations (CDMO) play in it. This analysis includes a review of the global CDMO market by-service type, drug molecule type and end use.
Rare Disease Diagnostics: Technologies and Global Markets
This report provides an overview of rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2023 and 2024, and then forecast through 2029.
Laboratory Animal Models, 3D Cultures and Organoids: Global Markets
This report provides detailed exposure to the laboratory animal model, 3D cell culture and organoids market. This report will highlight current and future market potential and a detailed analysis of the competitive environment.
Breakthrough Therapies: Market Dynamics and Investment Opportunities
This report provides an overview of the current regulatory environment, possible applications for breakthrough therapy designation (BTD) in other parts of the world, and ways to combine BTD with early access to medication programs to enhance patient access to medication for the treatment of rare diseases and high unmet clinical needs.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report provides an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2023.
High-Throughput Screening: Technologies and Global Markets
This report provides an analysis of the global high-throughput screening (HTS) market. It includes major market dynamics and current trends within the industry.
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
This report encompasses the global and regional markets for Alzheimer’s therapeutics and diagnostics.